Lataa...
De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival
Bronchiectasis occurs de novo in haematological malignancy and is associated with significant mortality and morbidity. Rituximab predisposes to IgG deficiency and survival time is significantly associated with age, FEV(1) % and stem cell transplantation. http://bit.ly/2KZwCZt
Tallennettuna:
| Julkaisussa: | ERJ Open Res |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
European Respiratory Society
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826250/ https://ncbi.nlm.nih.gov/pubmed/31720297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00166-2019 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|